Wealthfront Advisers LLC Takes $3.40 Million Position in Humana Inc. $HUM

Wealthfront Advisers LLC purchased a new stake in shares of Humana Inc. (NYSE:HUM) during the 2nd quarter, HoldingsChannel.com reports. The institutional investor purchased 8,549 shares of the insurance provider’s stock, valued at approximately $3,396,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Revolve Wealth Partners LLC bought a new stake in Humana during the fourth quarter valued at about $202,000. Woodline Partners LP grew its holdings in shares of Humana by 460.0% during the 1st quarter. Woodline Partners LP now owns 10,192 shares of the insurance provider’s stock worth $2,697,000 after purchasing an additional 8,372 shares in the last quarter. Sivia Capital Partners LLC increased its holdings in Humana by 53.7% in the 2nd quarter. Sivia Capital Partners LLC now owns 1,293 shares of the insurance provider’s stock valued at $316,000 after buying an additional 452 shares during the period. Cresset Asset Management LLC increased its stake in Humana by 10.3% in the second quarter. Cresset Asset Management LLC now owns 2,369 shares of the insurance provider’s stock valued at $581,000 after acquiring an additional 222 shares during the period. Finally, WINTON GROUP Ltd grew its stake in shares of Humana by 58.5% in the 2nd quarter. WINTON GROUP Ltd now owns 2,381 shares of the insurance provider’s stock valued at $582,000 after purchasing an additional 879 shares during the period. Institutional investors and hedge funds own 92.38% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have issued reports on HUM. Zacks Research lowered Humana from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, August 11th. Wells Fargo & Company upgraded shares of Humana from an “equal weight” rating to an “overweight” rating and boosted their price objective for the stock from $227.00 to $502.00 in a research report on Monday, July 13th. Oppenheimer reissued an “outperform” rating and set a $405.00 price objective on shares of Humana in a report on Thursday, July 30th. Guggenheim increased their price target on Humana from $269.00 to $471.00 and gave the company a “buy” rating in a research note on Thursday, July 30th. Finally, Leerink Partners raised shares of Humana from a “market perform” rating to an “outperform” rating and set a $513.00 price objective on the stock in a research note on Thursday, July 30th. Fourteen research analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Humana has an average rating of “Hold” and a consensus target price of $395.22.

Humana Trading Up 0.7%

NYSE HUM opened at $380.48 on Friday. Humana Inc. has a 52 week low of $163.11 and a 52 week high of $428.88. The stock’s 50 day moving average price is $383.38 and its two-hundred day moving average price is $280.90. The stock has a market capitalization of $45.69 billion, a price-to-earnings ratio of 36.00, a PEG ratio of 2.16 and a beta of 0.72. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.74 and a current ratio of 1.74.

Humana (NYSE:HUM) last released its earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share for the quarter, beating analysts’ consensus estimates of $7.27 by $0.34. Humana had a net margin of 0.88% and a return on equity of 11.20%. The business had revenue of $40.89 billion during the quarter, compared to the consensus estimate of $40.58 billion. During the same quarter last year, the firm earned $6.27 earnings per share. The firm’s revenue for the quarter was up 26.2% compared to the same quarter last year. As a group, analysts anticipate that Humana Inc. will post 9.08 earnings per share for the current fiscal year.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.